Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany35700-23-3 99%
Carboprost
Carboprost
Carboprost

35700-23-3 99%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2024-03-07

Product Details

  • Product NameCarboprost
  • CAS No.35700-23-3
  • MFC21H36O5
  • MW368.51
  • AppearanceSolidWhite
  • Melting point 79-82°C
  • storage temp. -20°C Freezer, Under Inert Atmosphere
  • Boiling point 418.83°C (rough estimate)
  • density 1.0390 (rough estimate)

Company Profile Introduction

Century Pharmaceuticals Ltd is in the business of manufacturing APIs for over three decades. We offer various kinds of services in addition to supplies of APIs, we undertake long-term contracts for manufacturing intermediates and development of new Active Pharmaceutical Ingredients as per your requirement. We have a sharp focus on giving value added services to our customers cost effectively.
We are supplying APIs to the global pharmaceutical companies in India and abroad since the last 3 decades. Some of our major customers operate in India and export to their products to other countries. Our customers like Teva Pharmaceuticals, Jubilant, Glenmark, Hetero Drugs, Macleod, Abbott, FDC, Wallace Pharma, Intas Pharmaceuticals, Cipla, Aristo pharmaceuticals and other Indian players in the Pharmaceutical industry source their APIs from us regularly.
As a Pharmaceutical company, we manufacture all the APIs which were developed in our own R&D. Currently our R&D is involved in the development of few more API products. We have a Biotech drug discovery R&D jointly developed with an Israeli partner for the development of Recombinant fusion proteins for the treatment and cure of asthma and Mastocytosis.

Century Pharmaceuticals Ltd

1Y Gujarat India
  • Since:2020-03-01
  • Address: 406, World Trade Centre, Sayajigunj, Vadodara, Gujarat-390005, India.
INQUIRY